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During embryonic liver development, hepatic stem/
progenitor cells (HpSCs) have a high proliferative
ability and bipotency to differentiate into hepatocytes
and cholangiocytes. Retinoic acid is a derivative of
vitamin A and is involved in the proliferation and
differentiation of stem/progenitor cells in several
tissues. However, whether retinoic acid regulates the
characteristics of HpSCs in the normal liver is still
unknown. A recent study has shown that acyclic
retinoid regulates the survival and proliferation of
HpSCs derived from mouse foetal liver. Acyclic retinoid
suppressed the expansion of CD29+CD49f+ HpSCs
through the induction of hepatocytic differentiation
and progression of apoptosis.Dlk, Liv2, E-cadherin, CD13, and CD133 are reported toIntroduction
The liver is the largest organ in the adult human body
and is important for maintaining homeostasis. Adult he-
patocytes and liver parenchymal cells express genes and
enzymes for several metabolic functions. In addition, the
liver includes several non-parenchymal cells such as
cholangiocytes, sinusoidal endothelial cells, stellate cells,
and Kupffer cells. Hepatocytes and cholangiocytes are
differentiated from the same source: the stem/progenitor
cells in embryonic livers. Guan and colleagues, in a recent
article in Stem Cell Research & Therapy, investigated a
new mechanism regulating the survival and differentiation
of these stem/progenitor cells by retinoic acid signals [1].
There are two types of liver progenitor cells: foetal
hepatic progenitor cells and postnatal/adult hepatic pro-
genitor cells. Liver formation begins with the specifica-
tion of the foetal hepatic progenitor cells derived from
the foregut endoderm. During mid- to late-foetal liverCorrespondence: kamiyaa@tokai-u.jp
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unless otherwise stated.development, hepatic progenitor cells differentiate into
hepatocytes and cholangiocytes. It has been reported that
the interaction between hepatic cells and hematopoietic
cells is important for foetal liver maturation [2]. Moreover,
in cases of serious injury to the adult liver, such as that
induced by retrorsine or 2-acetylaminofluorine treat-
ment in combination with partial hepatectomy, the
number of characteristic progenitor-like cells expressing
both cholangiocellular and hepatocellular markers in-
creases in periportal regions [3].
These foetal and adult hepatic progenitor cells are well
characterized by specific cell surface antibodies and cell
purification methods such as flow cytometry. Suzuki and
colleagues [4] found CD29 and CD49f to be specific
markers and established in vitro colony formation assays
of hepatic progenitor cells. In addition, markers such as
be specific markers of foetal hepatic progenitor cells.
CD13 and CD133 are also expressed in progenitor cells
derived from adult livers. Recent studies revealed that
long-term proliferative hepatic progenitor cells exist in
mouse and human adult livers. LGR5+ and EpCAM+
progenitor cells can form cystic structures and expand
in vitro for several months [5, 6]. An in vitro culture sys-
tem of purified cells using antibodies against these cell
surface antigens is useful for analyses of molecular
mechanisms regulating the proliferation and differenti-
ation of hepatic progenitor cells.
It is known that, in addition to stem/progenitor cells
in the normal liver, cancer stem-like cells are present in
hepatocellular carcinomas (HCCs) or other types of can-
cers. Cancer stem-like cells have characteristics similar
to those exhibited by somatic stem cells and are import-
ant for tumour initiation, metastasis, and recurrence.
Retinoic acid is a natural derivative of vitamin A and
regulates its target genes by binding to nuclear receptors
such as retinoic acid receptors (RARs) and retinoid X
receptors (RXRs). Retinoic acid is important for the differ-
entiation and proliferation of stem/progenitor cells in bothis an Open Access article distributed under the terms of the Creative Commons
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used for the differentiation of pluripotent stem cells into
mature functional cells. In addition, acyclic retinoid (ACR)
exhibited anti-HCC effects in several hepatoma models [7,
8]. In contrast, liver regeneration in vivo is induced by the
addition of all-trans retinoic acid (ATRA) [9]. Thus, the
exact effects of retinoic acid signals on normal hepatic
stem/progenitor cells (HpSCs) in somatic tissues remain
unknown.
Guan and colleagues [1] stated that the addition of
ACR regulated the survival and differentiation of HpSCs
derived from mouse embryonic liver. Peretinoin is a syn-
thetic ACR that has been known to reduce the risk of
HCC recurrence or death. In addition, peretinoin in-
hibits the replication and release of hepatitis C virus
[10]. Guan and colleagues isolated HpSCs by using spe-
cific cell surface antigens (CD29 and CD49f) and flow
cytometry and cultured them in a low-density colony
assay system. These cells have a high colony-forming
ability and express several retinoic acid-binding recep-
tors - namely, Rarα, Rxrα, and Rxrβ - at higher levels
than those expressed by adult hepatocytes. The addition
of peretinoin significantly reduced the total number of
cells and colony formation by HpSCs in a dose-dependent
manner. After peretinoin treatment, the clonal expansion
of HpSCs was suppressed and the colony size was signifi-
cantly reduced. In addition, the expression of the cell cycle
gene cyclin D1 was decreased whereas the expression of
cdk inhibitor p21Cip1 was upregulated by the addition of
peretinoin. These results suggested that ACR inhibits the
expansion of stem/progenitor cells derived from embry-
onic livers. This cell cycle arrest is involved in the differen-
tiation of HpSCs. The authors found that ACR induced
maturation of HpSCs into hepatocytic cells. The addition
of peretinoin induced the expression of cells positive for
the hepatocyte marker albumin in this culture system. In
contrast, the HpSC marker genes such as α-feto protein,
Cd44, and Dlk were significantly downregulated by pereti-
noin. The expression of cytokeratin 19, a cholangiocyte
marker, was also decreased, suggesting that the addition of
ACR promoted hepatic differentiation, but not cholangio-
cytic differentiation, of HpSCs. In addition, ACR regulated
HpSC survival via apoptosis.
Guan and colleagues have provided evidence that ret-
inoic acids regulate proliferation and differentiation of
HpSCs during liver development. Whether retinoic acids
ATRA and ACR positively or negatively affect cell prolif-
eration in normal liver and hepatic carcinoma tissues is
controversial. The present study clearly showed that
ACR suppressed the proliferation and survival of stem/
progenitor cells in normal embryonic liver tissues. A
synthetic retinoid ACR might have a cell signal cascade
that is different from that of natural retinoic acids.
Hepatic cancer stem cells also exhibit stem/progenitorcharacteristics similar to those exhibited by normal
HpSCs. Therefore, this study suggested that ACR not
only plays the role of an anti-tumour drug in HCC but
also inhibits tumour-initiating cells such as hepatic
cancer stem cells.
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